Morgan Stanley’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $89.2K | Buy |
|
|||||
|
2023
Q2 | $18.5K | Buy |
|
|||||
|
2023
Q1 | $10.6K | Sell |
|
|||||
|
2022
Q4 | $127K | Buy |
|
|||||
|
2022
Q3 | $134K | Sell |
|
|||||
|
2022
Q2 | $294K | Buy |
|
|||||
|
2022
Q1 | $171K | Sell |
|
|||||
|
2021
Q4 | $306K | Sell |
|
|||||
|
2021
Q3 | $564K | Buy |
|
|||||
|
2021
Q2 | $732K | Sell |
|
|||||
|
2021
Q1 | $728K | Sell |
|
|||||
|
2020
Q4 | $1.11M | Buy |
|
|||||
|
2020
Q3 | $279K | Buy |
|
|||||
|
2020
Q2 | $231K | Buy |
|
|||||
|
2020
Q1 | $175K | Sell |
|
|||||
|
2019
Q4 | $223K | Sell |
|
|||||
|
2019
Q3 | $451K | Buy |
|
|||||
|
2019
Q2 | $576K | Buy |
|
|||||
|
2019
Q1 | $447K | Sell |
|
|||||
|
2018
Q4 | $737K | Buy |
|
|||||
|
2018
Q3 | $600K | Buy |
|
|||||
|
2018
Q2 | $210K | Buy |
|